Skip to main content

Table 4 Logistic regression analysis of the risk factors for CRC in diverted intestinal tract

From: Clinicopathological and prognostic evaluations of anorectal cancer after fecal diversion for patients with Crohn’s disease

Factors

Univariate analysis

Multivariate analysis

 

OR (95% CI)

p value

OR (95% CI)

p value

Male

2.79 (0.81–9.51)

0.10

3.15 (0.78–12.77)

0.10

Type of CD (ileocolitis)

2.31 (0.26–20.33)

0.44

1.46 (0.12–17.42)

0.76

Duration from diagnosis to stoma creation  205 (months)

1.00 (0.90–1.01)

0.07

6.85 (1.76–26.72)

0.17

Indication of stoma (anorectal lesion)

0.32 (0.04–2.63)

0.29

0.25(0.02–2.40)

0.23

Site of stoma (ileostomy or jejunostomy)

2.22 (0.63–7.84)

0.21

2.56 (0.62–10.64)

0.19

Type of stoma (loop stoma)

1.80 (0.51–6.36)

0.35

3.27 (0.79–13.57)

0.10

Continuous symptom after stoma creation

0.24 (0.03–1.95)

0.18

0.16 (0.01–1.47)

0.10

Biologic administration

2.63 (0.52–13.3)

0.33

2.12 (0.29–15.03)

0.45

Duration of CD  77 (months)

0.99 (0.98–1.00)

0.20

0.96 (0.89–1.04)

0.43

Duration of fecal diversion  65 (months)

0.99(0.98–1.00)

0.21

1.02 (0.94–1.10)

0.51

  1. CD Crohn's disease, CI confidence interval, ARC anorectal cancer, OR odds ratio